Market Closed - Nasdaq Copenhagen 10:59:35 2024-04-18 am EDT 5-day change 1st Jan Change
311 DKK -0.89% Intraday chart for Demant A/S -6.21% +5.07%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Denmark's Demant Finalizes Capital Reduction MT
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business MT
Demant Seeks Acquisitions CI
Transcript : Demant A/S - Analyst/Investor Day
Nordic Stocks Closed Down Wednesday; Electrolux Series a Posted Biggest Loss DJ
Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S CI
Nordic Shares Rose Tuesday; Demant Climbed Highest DJ
DEMANT : In-line Q4; markets cheer the promising takeaways for 2024 Alphavalue
Global markets live: BP, Palantir, Infineon, Toyota, UBS... Our Logo
Transcript : Demant A/S, 2023 Earnings Call, Feb 06, 2024
US Futures Mixed, European Stocks Rise as Investors Parse More Fedspeak DJ
Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021. CI
Demant A/S Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Demant Forecasts Up to 8% Organic Revenue Growth in FY24 MT
Demant to Explore Strategic Options for Communications Business Amid Weak Market Conditions MT
Demant A/S Provides Earnings Guidance for the Year 2024 CI
Demant A/S Promotes Peter Pudselykke as Head of Investor Relations Effective 1 March 2024 CI
Demant to Recommence Share Buybacks MT
Nordic Stocks Dropped Tuesday; Demant Took Biggest Hit DJ
DEMANT : Sales broadly in-line; guidance narrowed Alphavalue
Transcript : Demant A/S, Q3 2023 Interim Management Statement Call, Nov 07, 2023
US Futures Slip, European Stocks Mostly Flat DJ
Demant Q3 revenue meets forecast, narrows outlook RE
Demant A/S Provides Earnings Guidance for the Year 2023 CI
European Commission OKs Cochlear's Aquisition of Oticon Medical Unit MT
Chart Demant A/S
More charts
Demant A/S is the world's 2nd leading producer of audio products. Net sales (excluding activities held for sale) break down by family of products as follows: - tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands; - hearing care products (40.5%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica; - diagnostic products (1116%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan; - business communication solutions (3.7%). Net sales (excluding activities held for sale) are distributed geographically as follows: Denmark (1.2%), France (9.9%), Europe (29.7%), the United States (34.1%), North America (7%), Asia (10.4%), Pacific (4.9%) and other (2.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
313.8 DKK
Average target price
334.1 DKK
Spread / Average Target
+6.48%
Consensus
  1. Stock Market
  2. Equities
  3. DEMANT Stock
  4. News Demant A/S
  5. Hearing Care Group Demant To Sell Hearing Implants Unit For $121 Million